GMP CELL BANKING SERVICES MARKET ANALYSIS | Coherent Market Insights - PowerPoint PPT Presentation

About This Presentation
Title:

GMP CELL BANKING SERVICES MARKET ANALYSIS | Coherent Market Insights

Description:

Read here the latest updates on the GMP CELL BANKING SERVICES MARKET ANALYSIS published by CMI team. – PowerPoint PPT presentation

Number of Views:76

less

Transcript and Presenter's Notes

Title: GMP CELL BANKING SERVICES MARKET ANALYSIS | Coherent Market Insights


1
Coherent Marketing Insights
  • Market Research Business Consulting Services
  • https//www.coherentmarketinsights.com/
  • Covid-19 Impact Tracker

2
  • GMP CELL BANKING SERVICES MARKET ANALYSIS
  • GMP Cell Banking Services Market, By Cell Type
    (Mammalian, Microbial, Insect, Yeast, Avian, Stem
    Cell Type, Others), By End User
    (Biopharmaceutical Companies, Contract
    Manufacturing Organizations), and By Region
    (North America, Latin America, Europe, Asia
    Pacific, Middle East Africa) - Size, Share,
    Outlook, and Opportunity Analysis, 2019 - 2027

3
  • Statistics
  • The global GMP cell banking services market is
    estimated to account for US 1,326.8 Mn in terms
    of value by the end of XXX.
  • Global GMP Cell Banking Services Market Drivers
  • Increasing funding for RD in rare diseases is
    expected to boost growth of the global GMP cell
    banking services market over the forecast period.
    For instance, the U.S. Food and Drug
    Administration (FDA) funds research in rare
    diseases through congressionally mandated
    programs such as the Orphan Products Grants
    Program that supports natural history studies and
    clinical trials for rare diseases.
  • Moreover, establishment of stem cell banking
    resource centers is also expected to aid in
    growth of the market. For instance, in March
    2020, Stemlife Berhad, a cord blood bank in
    Malaysia, started a Stem Cell Banking Resource
    Center in Jerudong Park Medical Center, Brunei.

4
  • Figure 1. Global GMP Cell Banking Services Market
    Share (), by Region, 2019

5
  • Stringent regulatory requirements are expected to
    hinder growth of the global GMP cell banking
    services market. Quality of the master and
    working cell banks must be monitored and
    confirmed on a continuous basis to justify the
    continuation of the production processes. The
    data collected from these analytical tests is a
    regulatory requirement for maintaining the
    biologic license and distribution of marketed
    product. The European Medicines Agency (EMA) and
    the U.S. FDA, in collaboration with other
    regulatory agencies worldwide, formed the
    International Council for Harmonization of
    Technical Requirements for Pharmaceuticals for
    Human Use (ICH), which set forth guidelines for
    good manufacturing practices. Specifically, ICH
    guidelines Q5, Q6 and Q7 are applicable to cell
    banks used in production processes.
  • Global GMP Cell Banking Services Market
    Opportunities
  • Several pharmaceutical and biotechnology
    companies are increasingly seeking full service
    in the form of global partners that can be
    outsourced the entire manufacturing process. This
    in turn is expected to offer lucrative growth
    opportunities for players in the market.

6
Market Trends/Key Takeaways
  • The demand for ready-to-use bioassay banks has
    significantly increased. Ready-to-use bioassay
    banks are used in situations where cells are used
    straight from the vial in the bioassay, thereby
    eliminating the cell expansion step. Ready-to-use
    bioassay banks are typically large in size,
    commonly ranging between 400-1000 vials and have
    large cell densities per vial.Major players in
    the market are focused on adopting MA strategies
    to expand their product portfolio. For instance,
    in January 2020, Charles River Laboratories
    International, Inc. acquired HemaCare Corporation
    for around US 380 million in cash.
  • Regulations U.S.Section 501(a)(2)(B) of the
    FDC Act 21 CFR parts 210 and 211 and 21 CFR
    part 600
  • All manufacturing facilities to ensure compliance
    with cGMP regulations
  • cGMP includes the implementation of oversight and
    controls over the manufacture of drugs to ensure
    quality, including managing the risk of and
    establishing the safety of raw materials,
    materials used in the manufacturing of drugs, and
    finished drug products.

7
21 CFR 211.22(d)
  • Requirement of the quality unit of a
    pharmaceutical company to monitor adherence to
    regulations by a CMO

8
Global GMP Cell Banking Services Market
Competitive Landscape
  • Major players operating in the global GMP cell
    banking services market include, WuXi AppTec
    Group, Charles River Laboratories International,
    Inc., Eurofins Scientific, Merck KGaA, Lonza
    Group Ltd., SGS Ltd., ViruSure GmbH, Austrianova,
    Goodwin Biotechnology Inc., and Paragon
    Bioservices, Inc.
  • Global GMP Cell Banking Services Market Key
    Developments
  • Major players in the market are focused on
    adopting collaboration strategies to expand their
    product portfolio. For instance, in March 2020,
    Lonza collaborated with Stanford University
    School of Medicine, Fred Hutchinson Cancer
    Research Center, and Parker Institute for Cancer
    Immunotherapy for RD in cell therapy.
  • Major players in the market are also focused on
    adopting various marketing strategies to expand
    their customer base. For instance, in January
    2020, Charles River Laboratories International,
    Inc. presented at the 38th Annual J.P. Morgan
    Healthcare Conference in San Francisco,
    California, U.S.

9
  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Referance https//www.coherentmarketinsights.com/
    market-insight/gmp-cell-banking-services-market-36
    34

10
About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions. We are headquartered
    in India, having office at global financial
    capital in the U.S. Our client base includes
    players from across all business verticals in
    over 150 countries worldwide.
  • What We ProvideCustomized Market Research
    AnalysisIndustry Analysis ServicesBusiness
    Consulting ServicesLong Term Engagement
    ModelCountry Specific Analysis

11
Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt. LTD.Coherent
    Market Insights 1001 4th Ave, 3200 Seattle, WA
    98154, U.S.Phone 1-206-701-6702
  • Email sales_at_coherentmarketinsights.com

12
Thank You
  • Kindly Follow CMI Social Media Profiles for the
    latest Company Updates.
  • Facebook
  • Linkedin
  • Twitter
  • https//www.coherentmarketinsights.com/
Write a Comment
User Comments (0)
About PowerShow.com